JP2014531417A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531417A5
JP2014531417A5 JP2014527635A JP2014527635A JP2014531417A5 JP 2014531417 A5 JP2014531417 A5 JP 2014531417A5 JP 2014527635 A JP2014527635 A JP 2014527635A JP 2014527635 A JP2014527635 A JP 2014527635A JP 2014531417 A5 JP2014531417 A5 JP 2014531417A5
Authority
JP
Japan
Prior art keywords
group
formula
ring
alkyl
och
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527635A
Other languages
English (en)
Japanese (ja)
Other versions
JP6240072B2 (ja
JP2014531417A (ja
Filing date
Publication date
Priority claimed from DE102011111991A external-priority patent/DE102011111991A1/de
Application filed filed Critical
Publication of JP2014531417A publication Critical patent/JP2014531417A/ja
Publication of JP2014531417A5 publication Critical patent/JP2014531417A5/ja
Application granted granted Critical
Publication of JP6240072B2 publication Critical patent/JP6240072B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527635A 2011-08-30 2012-08-29 シクロスポリン誘導体 Expired - Fee Related JP6240072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011111991A DE102011111991A1 (de) 2011-08-30 2011-08-30 Neue Cyclosporin-Derivate
DE102011111991.8 2011-08-30
PCT/EP2012/066726 WO2013030208A1 (de) 2011-08-30 2012-08-29 Cyclosporin-derivate

Publications (3)

Publication Number Publication Date
JP2014531417A JP2014531417A (ja) 2014-11-27
JP2014531417A5 true JP2014531417A5 (cg-RX-API-DMAC7.html) 2017-01-19
JP6240072B2 JP6240072B2 (ja) 2017-11-29

Family

ID=46754993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527635A Expired - Fee Related JP6240072B2 (ja) 2011-08-30 2012-08-29 シクロスポリン誘導体

Country Status (9)

Country Link
US (1) US9453051B2 (cg-RX-API-DMAC7.html)
EP (1) EP2751127B1 (cg-RX-API-DMAC7.html)
JP (1) JP6240072B2 (cg-RX-API-DMAC7.html)
CN (1) CN103842372A (cg-RX-API-DMAC7.html)
AU (1) AU2012300934B2 (cg-RX-API-DMAC7.html)
CA (1) CA2845663C (cg-RX-API-DMAC7.html)
DE (1) DE102011111991A1 (cg-RX-API-DMAC7.html)
ES (1) ES2601029T3 (cg-RX-API-DMAC7.html)
WO (1) WO2013030208A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0737730Y2 (ja) 1989-10-04 1995-08-30 横河電機株式会社 溶射装置
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
CN104513296B (zh) * 2013-09-27 2018-03-02 王喆明 一种环肽化合物及其用途
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
CA3000822A1 (en) * 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
CA3020594A1 (en) 2016-04-12 2017-10-19 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
US12594275B2 (en) 2019-02-07 2026-04-07 The Regents Of The University Of California Immunophilin binding agents and uses thereof
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
CN121471132A (zh) 2019-11-04 2026-02-06 锐新医药公司 Ras抑制剂
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021173474A1 (en) * 2020-02-26 2021-09-02 Bacainn Biotherapeutics, Ltd. Cyclosporine compositions and methods of use
CA3172535A1 (en) * 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy
WO2022192716A1 (en) * 2021-03-11 2022-09-15 Massachusetts Institute Of Technology Small molecule suppressors of apoe gene expression and cerebral vascular amyloid pathology
CN112919984B (zh) * 2021-04-16 2022-03-08 安徽硒无忧现代农业科技有限公司 一种生态化富硒有机营养液及其制备方法
IL308195A (en) 2021-05-05 2024-01-01 Revolution Medicines Inc RAS inhibitors for cancer treatment
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
US4672044A (en) 1984-08-24 1987-06-09 Scripps Clinic & Research Foundation Murine monoclonal antibody combining site to human C3b receptor (CR1)
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
AT401823B (de) 1993-09-30 1996-12-27 Avl Verbrennungskraft Messtech Optischer indikator zur bestimmung der aktivität eines ions in einer probe
AUPO395396A0 (en) 1996-12-02 1997-01-02 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
PT848009E (pt) * 1996-12-16 2000-11-30 Pharmachemie Bv Processo para a preparacao de epirubicina ou seus sais de adicao de acido a partir de daunorubicina
CA2285454A1 (en) 1997-04-07 1998-10-15 Axys Pharmaceuticals Corporation Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
FR2762843B1 (fr) * 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
DE69832984T2 (de) 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
US6221914B1 (en) 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
WO2000020400A1 (en) 1998-10-05 2000-04-13 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating hepatitis c infections
DE19859910C2 (de) 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
IL135884A (en) 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
US6596499B2 (en) 2000-11-30 2003-07-22 The Netherlands Cancer Institute Membrane molecule indicator compositions and methods
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
WO2003087089A1 (en) 2002-04-16 2003-10-23 Teijin Limited Piperidine derivatives having ccr3 antagonism
AU2003285958A1 (en) 2002-10-25 2004-05-25 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
DE10339597A1 (de) 2003-08-26 2005-03-31 Bayer Technology Services Gmbh Vorrichtung und Verfahren zum Nachweis biochemischer Aktivität enthaltend Gap Junctions
AU2004276337B2 (en) 2003-09-24 2009-11-12 Methylgene Inc. Inhibitors of histone deacetylase
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7622583B2 (en) 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
DE102006038403A1 (de) 2006-08-17 2008-02-21 Heinrich-Heine-Universität Düsseldorf Verwendung bestimmter chemischer Verbindungen zur Inhibierung der Peptidyl-Prolyl-cis/trans-Isomeraseaktivität von Cyclophilinen
SG144809A1 (en) 2007-01-11 2008-08-28 Millipore U K Ltd Benzimidazole compounds and their use as chromatographic ligands
PL1990405T3 (pl) * 2007-05-08 2018-01-31 Provivo Oy Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe
US20100009390A1 (en) * 2008-05-09 2010-01-14 The Regents Of The University Of California Mutant antibodies with high affinity for egfr
MX2011001152A (es) 2008-07-30 2011-06-09 Isotechnika Pharma Inc Moleculas de analogo de ciclosporina no-inmunesupresoras.
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
US8481483B2 (en) * 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
DE102009037551A1 (de) 2009-08-17 2011-02-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Cyclosporinderivate

Similar Documents

Publication Publication Date Title
JP6240072B2 (ja) シクロスポリン誘導体
JP2017517508A5 (cg-RX-API-DMAC7.html)
JP2018524339A5 (cg-RX-API-DMAC7.html)
JP2008540389A5 (cg-RX-API-DMAC7.html)
ES2924058T3 (es) Polimixinas antimicrobianas para el tratamiento de infecciones bacterianas
TW201107318A (en) Furazanobenzimidazoles
JP2013540102A5 (cg-RX-API-DMAC7.html)
PT1965798E (pt) Antibióticos de monobactama úteis
CN104902895A (zh) 可用作用于治疗增生性疾病的激酶抑制剂的二氢萘啶和相关化合物
HRP20130900T1 (hr) Derivat (aza)indola i njegova uporaba u medicinske svrhe
CA2962922C (en) Sphingosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
ES2593275T3 (es) Compuestos herbicidas
JP2008546770A5 (cg-RX-API-DMAC7.html)
WO2012150537A2 (es) Nuevas formas sólidas de antibióticos
JP2018502845A5 (cg-RX-API-DMAC7.html)
JP2017516821A (ja) ナフチリジンジオン誘導体
KR20240136386A (ko) 대사 및 간 장애 치료를 위한 약학 제제 및 방법
JP2016529235A5 (cg-RX-API-DMAC7.html)
JP2025148472A (ja) 緑膿菌病原性因子LasBの阻害剤
JP2006502214A5 (cg-RX-API-DMAC7.html)
ES2544086T3 (es) Derivados de 2-metoxi-piridin-4-ilo
JP2013544880A5 (cg-RX-API-DMAC7.html)
CN105616408B (zh) 吡啶并[3,4-b]吲哚衍生物作为IDO抑制剂的用途
IL305099A (en) Small molecule activators of yap transcriptional activity for regenerative organ repair
JP2006523705A5 (cg-RX-API-DMAC7.html)